Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SkinSeqnc is a biotechnology and consumer health company that leverages skin microbiome sequencing to provide personalized skincare solutions. Founded by board-certified dermatologists, the company utilizes a proprietary platform to analyze the unique microbial composition of an individual's skin. This data-driven approach allows for the identification of specific imbalances associated with conditions like acne, eczema, and aging. SkinSeqnc provides users with detailed reports and tailored product recommendations to optimize skin health and barrier function. By integrating clinical expertise with advanced genomic technology, the company aims to move skincare from trial-and-error to a precise, scientific discipline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SKINSEQNC.